Crossref
Authors’ response to: SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence
Clinical Diabetology · 2026-07-20
DOI: 10.5603/cd.112501 ↗At a glance
Journal article in Clinical Diabetology, published online on 2026-07-20. Written by Katarzyna Joanna Jakuszko and 2 co-authors.
Abstract (original language)
Abstract non disponibile.
Cite
APA
Jakuszko, K. J., Zmonarski, S. C., & Banasik, M. A. (2026). Authors’ response to: SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. https://doi.org/10.5603/cd.112501
Vancouver
Jakuszko KJ, Zmonarski SC, Banasik MA. Authors’ response to: SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. 2026. doi:10.5603/cd.112501
BibTeX
@article{Jakuszko2026,
author = {Jakuszko, Katarzyna Joanna and Zmonarski, Sławomir Cezary and Banasik, Mirosław Adam},
title = {Authors’ response to: SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence},
journal = {Clinical Diabetology},
year = {2026},
doi = {10.5603/cd.112501}
}
EUVIMED